Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07027033

Nutritional Oleic Acid Modulation of adIpose Cholesterol Metabolism in Patients Living With Obesity

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Nantes University Hospital · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Disruption of white adipose tissue (WAT) homeostasis during obesity is central to the development of associated cardiometabolic complications. Dietary supplementation with oleic acid in obese patients can limit these complications. Experimental data, obtained in preclinical models, suggest that the beneficial effects of oleic acid may protect the TAB by increasing cholesterol esterification. The NAMICO study aims to test this hypothesis using TAB biopsies collected from obese patients undergoing bariatric surgery who had previously undergone dietary enrichment with either a conventional oil or an oil rich in oleic acid.

Conditions

Interventions

TypeNameDescription
OTHERacid-rich sunflower oil oleic acidNutritional intervention for 13 weeks ± 2 weeks, including 40 millilitres of sunflower oil rich in oleic acid
OTHERconventional sunflower oilNutritional intervention for 13 weeks ± 2 weeks, including 40 millilitres of conventional sunflower oil

Timeline

Start date
2025-07-15
Primary completion
2028-07-01
Completion
2028-07-01
First posted
2025-06-18
Last updated
2026-01-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07027033. Inclusion in this directory is not an endorsement.